Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction
Aim. To study the effects of long-term bisoprolol (B) therapy on exercise capacity (EC) dynamics, ventricular arrhythmia (VA), and clinical course in patients with myocardial infarction (MI). Material and methods. The study included 114 men with MI (age 30-63 years), receiving long-term B treatment...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1662 |
| _version_ | 1797882575201501184 |
|---|---|
| author | R. T. Shukurov R. D. Kurbanov |
| author_facet | R. T. Shukurov R. D. Kurbanov |
| author_sort | R. T. Shukurov |
| collection | DOAJ |
| description | Aim. To study the effects of long-term bisoprolol (B) therapy on exercise capacity (EC) dynamics, ventricular arrhythmia (VA), and clinical course in patients with myocardial infarction (MI). Material and methods. The study included 114 men with MI (age 30-63 years), receiving long-term B treatment (2,5-10 mg once a day). The parameters assessed included EC dynamics, VA, and clinical course of the disease. Results. Patients with sub-acute MI were characterised by low EC and VA presence, including life-threatening VA forms. Long-term B treatment was associated with a significant reduction in angina attack rate (by 3,9 times) and in the number of nitroglycerin tablets per week (by 4,3 times). In most patients (79,7%), B therapy increased the work performed during stress test (+99%), EC (+43,4%), and exercise time (+52%). In 44 patients (55,7%), an antiarrhythmic effect was observed, including the individuals with high-grade VA (13 out of 15). Long-term B treatment also improved the clinical course of the disease, significantly reducing the end-point rates (in 86,1%). Conclusion. Early started, adequate-dose long-term B therapy improved clinical course of the disease and demonstrated good anti-ischemic, antianginal, and antiarrhythmic effects in MI patients, including those with life-threatening VA forms. |
| first_indexed | 2024-04-10T03:37:58Z |
| format | Article |
| id | doaj.art-0c2b0eb1bd7342468fa4faf6a26b0db8 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:37:58Z |
| publishDate | 2011-04-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-0c2b0eb1bd7342468fa4faf6a26b0db82023-03-13T07:23:19Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252011-04-01102606810.15829/1728-8800-2011-2-60-681380Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarctionR. T. Shukurov0R. D. Kurbanov1Республиканский специализированный центр кардиологииРеспубликанский специализированный центр кардиологииAim. To study the effects of long-term bisoprolol (B) therapy on exercise capacity (EC) dynamics, ventricular arrhythmia (VA), and clinical course in patients with myocardial infarction (MI). Material and methods. The study included 114 men with MI (age 30-63 years), receiving long-term B treatment (2,5-10 mg once a day). The parameters assessed included EC dynamics, VA, and clinical course of the disease. Results. Patients with sub-acute MI were characterised by low EC and VA presence, including life-threatening VA forms. Long-term B treatment was associated with a significant reduction in angina attack rate (by 3,9 times) and in the number of nitroglycerin tablets per week (by 4,3 times). In most patients (79,7%), B therapy increased the work performed during stress test (+99%), EC (+43,4%), and exercise time (+52%). In 44 patients (55,7%), an antiarrhythmic effect was observed, including the individuals with high-grade VA (13 out of 15). Long-term B treatment also improved the clinical course of the disease, significantly reducing the end-point rates (in 86,1%). Conclusion. Early started, adequate-dose long-term B therapy improved clinical course of the disease and demonstrated good anti-ischemic, antianginal, and antiarrhythmic effects in MI patients, including those with life-threatening VA forms.https://cardiovascular.elpub.ru/jour/article/view/1662инфаркт миокардабисопрололтолерантность к физической нагрузкежелудочковая аритмия |
| spellingShingle | R. T. Shukurov R. D. Kurbanov Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction Кардиоваскулярная терапия и профилактика инфаркт миокарда бисопролол толерантность к физической нагрузке желудочковая аритмия |
| title | Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction |
| title_full | Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction |
| title_fullStr | Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction |
| title_full_unstemmed | Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction |
| title_short | Anti-ischemic and antiarrhythmic effectiveness of long-term bisoprolol therapy in patients with myocardial infarction |
| title_sort | anti ischemic and antiarrhythmic effectiveness of long term bisoprolol therapy in patients with myocardial infarction |
| topic | инфаркт миокарда бисопролол толерантность к физической нагрузке желудочковая аритмия |
| url | https://cardiovascular.elpub.ru/jour/article/view/1662 |
| work_keys_str_mv | AT rtshukurov antiischemicandantiarrhythmiceffectivenessoflongtermbisoprololtherapyinpatientswithmyocardialinfarction AT rdkurbanov antiischemicandantiarrhythmiceffectivenessoflongtermbisoprololtherapyinpatientswithmyocardialinfarction |